Primex Pharmaceuticals Appoints Alan Knox as Head of Global Marketing
Swiss pharmaceutical company Primex Pharmaceuticals AG announces the appointment of Alan Knox as Head of Global Marketing. On July 1, 2016, he joins Primex Pharmaceuticals’ Executive Management Team.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160601005092/en/
Alan Knox (Photo: Business Wire)
Most recently, Alan Knox worked for MSD International AG as VP Global Marketing. At MSD, he has also held responsibilities for Global Portfolio Strategy and Regional Operations in EU/EEMEA. Prior to joining MSD, he held line management roles in Sandoz and AstraZeneca.
Mr. Knox will be in charge of the global go-to-market strategy for a novel solution for pediatric anesthesiology, recently acquired from Advicenne. He has previous experience with the launch of Diprivan (propofol) in the UK and emerging markets.
In February 2016, Primex Pharmaceuticals acquired the global rights for an advanced oral pharmaceutical candidate for pediatric anesthesiology. With this acquisition, Primex Pharmaceuticals expanded its portfolio with a unique product whose market potential is evaluated as hundreds of millions of euros.
Panu Paappanen, Chairman of the Board and Owner, commented: “2016 could mark a milestone for Primex Pharmaceuticals. By strengthening our organization, we secure the in-house expertise needed to realize the full potential of our acquisition and build our anesthesia pipeline.”
Kari Sarvanto, President and Co-Founder of Primex Group, added: “I am excited to welcome a highly experienced colleague to our team to bring the new, patient-friendly solution to the market. We are committed to making Primex Pharmaceuticals the leading global anesthesia pharmaceutical company.”
About Primex Pharmaceuticals
Primex Pharmaceuticals is a fast growing global specialty company spearheading a new lean pharmaceutical business model.
Primex aims to become the leading global innovative Anesthesia company helping patients undergo a wide range of medical procedures. With a portfolio of strong, trusted anesthesia products including Recofol N (propofol) acquired from Bayer, and the recent acquisition of a novel, oral solution pharmaceutical candidate for pediatric anesthesiology from Advicenne, Primex Pharmaceuticals will continue to identify and acquire new medications that complete the ‘Triad of Anesthesia’.
Primex Pharmaceuticals' global partner network operates in over 40 countries and reaches a population of one billion. The company is headquartered in Zug, Switzerland; all Primex products are manufactured in the EU. Primex Pharmaceuticals has proven underlying business operations and historically strong revenue growth.
More at www.Primexpharma.com
Mr Kari Sarvanto, President
Mobile: +41 796 162 694
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
JustPremium Launches Rich Video Product Suite19.3.2018 08:00 | Pressemelding
Programmatic rich media and video ad marketplace, JustPremium, has today announced the launch of a new product suite, Rich Video. The new offering allows clients to build multiple rich video ad units with a single click using the advertisers existing assets. Using Rich Video allows advertisers to create an engaging advert, leading to higher engagement and interaction rates. Ultimately these formats help create a better user experience and a higher return on investment. JustPremium launches this product at a time when quality video inventory has never been more in demand, and brand-safe video inventory that advertisers require has never been in shorter supply. Rich Video allows publishers to build multiple creative ad units in minutes, enabling them to test different options and optimise their message to give the best performance. By utilising the assets that have already been created for Facebook, Adwords and YouTube, this process allows advertisers to supercharge their existing conten
GovSat-1 Satellite Goes Operational19.3.2018 07:40 | Pressemelding
GovSat-1 enters operational service today, to provide secure communications to governmental and institutional users. GovSat-1 is the first satellite of GovSat, a public private partnership between the Government of Luxembourg and the world-leading satellite operator SES. The satellite was launched into space on 31 January on board a flight-proven SpaceX Falcon 9 rocket from Cape Canaveral Air Force Station, and has since undergone extensive testing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180319005458/en/ GovSat-1 launch. (Photo: SpaceX) The multi-mission satellite is operated by GovSat from the Secure Mission Operations Centre in Luxembourg. The highly flexible and resilient GovSat-1 payload uses dedicated frequencies in X-band and military Ka-band. It enables an array of applications such as connectivity for theatres of operation, interconnection of institutional or defence sites, border control, Intelligence, Surve
Digi Communications N.V.: Announcement on the Convocation Date for the Company’s GSM Approving the 2017 Annual Report19.3.2018 07:34 | Pressemelding
The Company would like to inform its investors and the market that the Board of Directors anticipates that on Wednesday, 21 March 2018, it will convene the general shareholders meeting (the “GSM”) called to approve, among others, the 2017 Annual Report. On the same date, the Company will make public, among others, its 2017 Annual Report and the auditor’s report. In accordance with the provisions of the articles of association of the Company, the GSM is scheduled to take place on 2 May 2018. Therefore, we would like to inform you with respect to the update to the Company’s Financial Reporting Calendar for 2018, which is available on Digi’s website. For details, please access the Digi’s website: www.digi-communications.ro (Investor Relations Section). About Digi Communications NV Digi is the parent holding company of RCS & RDS, a leading provider of pay TV and telecommunications services in Romania and Hungary. In addition, RCS & RDS provides mobile services as an MVNO to the large Roman
Dai Nippon Printing Chooses Gemalto’s Biometric Facial Recognition Solution to Facilitate Mobile Banking Access in Japan19.3.2018 06:00 | Pressemelding
Gemalto, the world leader in digital security, today announced that it has been selected by Dai Nippon Printing (DNP), a financial solutions provider in Japan, to make mobile banking transactions easier to use. Leveraging Gemalto’s facial biometric authentication solution - Mobile Protector- DNP has started to offer facial recognition to secure access to its mobile banking apps. This enables banking customers to easily and quickly log on to mobile banking services upon successful facial authentication, providing a more convenient user experience. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180318005005/en/ Facial recognition for mobile banking authentication. (Photo: Gemalto) Gemalto’s 2017 eBanking Trends research found that 68 percent of banks plan to implement facial recognition over the next five years. 80 percent of surveyed consumers perceived biometrics to be more secure than the traditional username and password co
Gemalto Helps European Banks Build Business Opportunities from PSD219.3.2018 06:00 | Pressemelding
Gemalto, the world leader in digital security, believes that the implementation of PSD2 (Payment Services Directive 2) offers European banks a unique opportunity to deliver digital innovation, robust protection and seamless user experience that will be critical in a new era of open markets. The Regulatory Technical Standards (RTS) have just been published in the EU Official Journal, and detail the responsibilities and obligations of all banking and payment stakeholders concerning access to account, customer data protection, user convenience, and payment security. Gemalto believes that long term success will be built around solutions tailored to individual requirements, whilst drawing on products and services already proven to deliver the core principles of PSD2. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180318005025/en/ Solutions to help financial institutions for implementation of PSD2. Credit: istockphoto Adoption of t
ExThera Medical Announces Creation of European Subsidiary19.3.2018 05:23 | Pressemelding
ExThera Medical Corporation, a developer of therapies for removing bacteria and viruses from blood, today announced the company’s plan to create ExThera Medical Europe and appointed Carla Kikken-Jussen as managing director of the new wholly-owned subsidiary. Carla brings more than 30 years of experience in clinical research and the commercialization of new medical devices in the European market to ExThera Medical, where she will oversee the strategic direction for ExThera’s European operations. “The establishment of our European subsidiary is an exciting milestone as we prepare for commercialization,” said Robert Ward, President and CEO of ExThera Medical. “Carla has a distinguished track record in medical device development and commercialization, including overseeing clinical research, regulatory affairs, quality assurance, and operations. As CEO of her company, Meditech, she successfully supported the rapid clinical adoption of many new medical devices. Carla’s strategic leadership w